Fosinopril

General

Type : Not A\/B H target || Drug || Pro-Drug || Pyrrolidine || Angiotensin-converting enzyme inhibitor || Organophosphate

Chemical_Nomenclature : (2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

Canonical SMILES : CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)O)C3CCCCC3

InChI : InChI=1S\/C30H46NO7P\/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24\/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)\/t25-,26+,30+,39-\/m1\/s1

InChIKey : BIDNLKIUORFRQP-XYGFDPSESA-N

Other name(s) : Fozitec,     Fosenopril,     C09AA09,     SQ-28555,     DB00492


MW : 563.7

Formula : C30H46NO7P

CAS_number : 98048-97-6

PubChem :

UniChem :

Iuphar :

References (4)

Title : Babesia BdFE1 Esterase is Required for the Anti-parasitic Activity of the ACE Inhibitor Fosinopril - Vydyam_2023_J.Biol.Chem__105313
Author(s) : Vydyam P , Choi JY , Gihaz S , Chand M , Gewirtz M , Thekkiniath J , Lonardi S , Gennaro JC , Ben Mamoun C
Ref : Journal of Biological Chemistry , :105313 , 2023
Abstract : Vydyam_2023_J.Biol.Chem__105313
ESTHER : Vydyam_2023_J.Biol.Chem__105313
PubMedSearch : Vydyam_2023_J.Biol.Chem__105313
PubMedID: 37797695
Gene_locus related to this paper: 9apic-BdFE1

Title : CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors - Wang_2016_Pharmacogenomics.J_16_220
Author(s) : Wang X , Wang G , Shi J , Aa JY , Comas R , Liang Y , Zhu HJ
Ref : Pharmacogenomics J , 16 :220 , 2016
Abstract : Wang_2016_Pharmacogenomics.J_16_220
ESTHER : Wang_2016_Pharmacogenomics.J_16_220
PubMedSearch : Wang_2016_Pharmacogenomics.J_16_220
PubMedID: 26076923
Gene_locus related to this paper: human-CES1

Title : Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma - Shah_2000_J.Cardiovasc.Pharmacol_36_169
Author(s) : Shah GB , Sharma S , Mehta AA , Goyal RK
Ref : J Cardiovasc Pharmacol , 36 :169 , 2000
Abstract : Shah_2000_J.Cardiovasc.Pharmacol_36_169
ESTHER : Shah_2000_J.Cardiovasc.Pharmacol_36_169
PubMedSearch : Shah_2000_J.Cardiovasc.Pharmacol_36_169
PubMedID: 10942157

Title : Fosinopril treatment of pregnant rats: developmental toxicity, fetal angiotensin-converting enzyme inhibition, and fetal angiotensin II receptor regulation - Grove_1995_Toxicol.Lett_80_85
Author(s) : Grove KL , Mayo RJ , Forsyth CS , Frank AA , Speth RC
Ref : Toxicology Letters , 80 :85 , 1995
Abstract : Grove_1995_Toxicol.Lett_80_85
ESTHER : Grove_1995_Toxicol.Lett_80_85
PubMedSearch : Grove_1995_Toxicol.Lett_80_85
PubMedID: 7482596